|
|
COMMUNIQUÉ DE PRESS
COMMUNIQUÉ DE PRESS
Mise à disposition du Document d’enregistrement universel 2021
et des documents préparatoires relatifs à l’assemblée générale
mixte du 12 mai 2022
Paris, France, le 27 avril 2022 ACTICOR BIOTECH ISIN : FR0014005OJ5 – ALACT, société de... Lire le communiqué |
|
| |
|
| |
|
|
PRESS RELEASE
Acticor Biotech:
Results of the Phase 2 GARDEN study
in COVID19related acute respiratory distress
syndrome
Paris, France, February 2, 2022, at 06:00pm CET – Acticor Biotech, a clinical... Lire le communiqué |
|
| |
|
| |
|
|
PRESS RELEASE
Acticor Biotech announces
coverage of its stock by Gilbert Dupont
and Kepler Cheuvreux
Paris, France, January 12, 2022 at 06:00 pm CET ACTICOR BIOTECH ISIN : FR0014005OJ5 – ALACT,
a clinical stage biopharmaceutical company dedicated to the development of... Lire le communiqué |
|
| |
|
| |
